Gastric cancer patients have higher levels of CCL5 than health volunteers.
Increased serum CCL5 levels are correlated with more advanced diseases and peritoneal metastasis.
Serum CCL5 concentrations have diagnostic values for gastric cancer peritoneal metastasis.
Higher levels of CCL5 in sera are a predictor for poorer survivals.